Rep. Thomas H. Kean, Jr. bought ESAB (ESAB)
Rep. Thomas H. Kean, Jr. (R-NJ-7) · $1K–$15K · traded Sep 29, 2026
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Sep 29, 2026
- Disclosed
- Oct 30, 2026
- Days to disclose
- 31
- Asset type
- Stock
- As filed
- ESAB Corporation Common Stock
- Industry
- Industrial - Machinery · Industrials
Other trades in this filing
- Oct 30, 2026$1K–$15K
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 30, 2026$1K–$15K
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and CommerceTraded 13 days before earnings - Oct 30, 2026$1K–$15K
Sold (partial) Mondelez International MDLZ
$1K–$15K · Traded Sep 23, 2026 · disclosed Oct 30, 2026
- Oct 30, 2026$1K–$15K
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
- Oct 30, 2026$1K–$15K
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce
Recent Congress trades in ESAB
- Aug 18, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Jul 7, 2026 · disclosed Aug 18, 2026
- Jul 15, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Jun 24, 2026 · disclosed Jul 15, 2026
- Jul 15, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Jun 22, 2026 · disclosed Jul 15, 2026
Company context for ESAB
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
ESAB: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-10-02. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
ESAB: Financial results
Filed 8-K for an event or period dated 2026-11-04. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.